The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

New research from Northwestern University shows 15-month-old infants can learn words for objects they've never seen. This ...

Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

Antibiotic use in preterm infants is linked to gut microbiome changes, increasing susceptibility to infections and impacting ...

A hypothesis by Rutgers Health researchers suggests a common stimulant could protect infants from sudden death.

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

Screening can now determine their risk for an ever-growing list of conditions — including ones we can’t do much about.

Infants who survive serious health problems in the first few weeks of life have a higher risk of dying during childhood and ...

Water sampling results done Saturday revealed nitrate levels of 11.9 milligrams per liter, according to Aqua Water. The ...

Aqua Illinois advises University Park, Peotone and Kankakee residents not to give tap water to infants due to high nitrate ...